Pleuroparenchymal fibroelastosis from a rheumatologic perspective
Therapeutic Advances in Respiratory Disease · 2026-05 · 20
DOI: 10.1177/17534666261445202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 06.05.2026. Verfasst von Maximiliano Diaz Menindez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Scleroderma, Systemic, Rheumatic Diseases, Autoimmune Diseases. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial lung disease (ILD) associated with systemic autoimmune rheumatic diseases (SARDs). Its clinical characteristics and outcomes in SARDs remain poorly defined.
Objectives
To describe demographics, imaging patterns, and outcomes in SARD-associated PPFE.
Methods
Patients diagnosed with PPFE and SARDs at Mayo Clinic (2000-2024) were included. PPFE diagnosis was confirmed by high-resolution computed tomography, and SARD diagnoses were established by rheumatologists.
Results
Fifteen of 62 patients with PPFE had SARDs with majority having systemic sclerosis (SSc)(n= 7, 46%). Median age at PPFE diagnosis was 57.2 years; 80% were female; 40% were ever-smokers; 40% required supplemental oxygen; 5 had pulmonary hypertension. Coexisting ILD patterns included UIP (26.7%) and NSIP (20%). Coexisting ILD patterns included usual interstitial pneumonia (26.7%) and nonspecific interstitial pneumonia (20%). Three patients died, including two with SSc.
Conclusion
Systemic sclerosis was the most frequently observed SARD among patients with PPFE, and may coexist with other ILD patterns; recognition may inform risk stratification, multidisciplinary evaluation, and longitudinal follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
- Division of Pulmonary and Sleep Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
- Mayo Clinic Alix School of Medicine, Phoenix, AZ, USA.
- Division of Rheumatology, Mayo Clinic Arizona, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA.
ORCID-Profile: Maximiliano Diaz Menindez
Zitieren
APA
Diaz Menindez, M., Diaz Arumir Vergara, A., Shing, V., Mead Harvey, C., Zamora Martinez, A. C., & Nagaraja, V. (2026). Pleuroparenchymal fibroelastosis from a rheumatologic perspective. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261445202
Vancouver
Diaz Menindez M, Diaz Arumir Vergara A, Shing V, Mead Harvey C, Zamora Martinez AC, Nagaraja V. Pleuroparenchymal fibroelastosis from a rheumatologic perspective. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261445202
BibTeX
@article{DiazMenindez2026,
author = {Diaz Menindez, Maximiliano and Diaz Arumir Vergara, Alejandro and Shing, Vivian and Mead Harvey, Carolyn and Zamora Martinez, Ana C and Nagaraja, Vivek},
title = {Pleuroparenchymal fibroelastosis from a rheumatologic perspective},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
volume = {20},
doi = {10.1177/17534666261445202}
}
EUVIMED